Kamlesh Haribhakti
Directeur Technique/Scientifique/R&D chez Vensun Pharmaceuticals, Inc.
Profil
Kamlesh Haribhakti is currently the Director, Chief Scientific Officer & EVP at Vensun Pharmaceuticals, Inc. He previously worked as the Director-Product Development at Able Laboratories, Inc.
Postes actifs de Kamlesh Haribhakti
| Sociétés | Poste | Début |
|---|---|---|
Vensun Pharmaceuticals, Inc.
 Vensun Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vensun Pharmaceuticals, Inc. engages in the development, manufacture, and supply of generic prescription drugs. It offers Crisoprodol tablets, Clopidogrel tablets, Donepezil Hydrochloride, Fluoxetine Capsules, Nystatin Topical powder, and Pramipexole Dihydrochloride tablets. The company was founded in July 2011 and is headquartered in Yardley, PA. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Kamlesh Haribhakti
| Sociétés | Poste | Fin |
|---|---|---|
| ABLE LABORATORIES INC. | Sales & Marketing | 07/12/2007 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
| Able Laboratories, Inc. | Health Technology |
Vensun Pharmaceuticals, Inc.
Vensun Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vensun Pharmaceuticals, Inc. engages in the development, manufacture, and supply of generic prescription drugs. It offers Crisoprodol tablets, Clopidogrel tablets, Donepezil Hydrochloride, Fluoxetine Capsules, Nystatin Topical powder, and Pramipexole Dihydrochloride tablets. The company was founded in July 2011 and is headquartered in Yardley, PA. | Health Technology |
